HERON THERAPEUTICS, INC. /DE/ Quarterly Costs and Expenses in USD from Q2 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Heron Therapeutics, Inc. /De/ quarterly/annual Costs and Expenses history and growth rate from Q2 2018 to Q3 2024.
  • Heron Therapeutics, Inc. /De/ Costs and Expenses for the quarter ending September 30, 2024 was $27.8M, a 27.1% decline year-over-year.
  • Heron Therapeutics, Inc. /De/ Costs and Expenses for the twelve months ending September 30, 2024 was $125M, a 15.4% decline year-over-year.
  • Heron Therapeutics, Inc. /De/ annual Costs and Expenses for 2023 was $173M, a 24.1% decline from 2022.
  • Heron Therapeutics, Inc. /De/ annual Costs and Expenses for 2022 was $227M, a 25.2% decline from 2021.
  • Heron Therapeutics, Inc. /De/ annual Costs and Expenses for 2021 was $304M, a 3.99% decline from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $125M $27.8M -$10.3M -27.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $136M $32M -$22.1M -40.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $158M $31M -$14.8M -32.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $173M $34.6M +$24.3M +238% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-12
Q3 2023 $148M $38.2M -$15.6M -29% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $164M $54M -$23.1M -30% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $187M $45.8M -$40.6M -47% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $227M $10.2M -$64M -86.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-12
Q3 2022 $291M $53.7M -$21.2M -28.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $313M $77.1M -$5.78M -6.98% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $318M $86.4M +$14.2M +19.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $304M $74.2M -$7.71M -9.41% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 $312M $74.9M -$3.41M -4.35% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $315M $82.9M +$4.5M +5.73% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $311M $72.1M -$6M -7.68% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $317M $81.9M -$12.5M -13.3% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-28
Q3 2020 $329M $78.3M +$872K +1.13% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $328M $78.4M -$10M -11.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $338M $78.1M -$18.2M -18.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $357M $94.4M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $77.5M +$15.9M +25.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $88.4M +$32.3M +57.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $96.3M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q3 2018 $61.6M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $56.1M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.